Moisturization and Skin Hydration Study

NCT ID: NCT07270965

Last Updated: 2025-12-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-12-31

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Skin moisturization is important for patients with atopic dermatitis, commonly known as eczema. Moisturizing right after bathing is widely accepted as the best method to keep skin hydrated. However, there is conflicting research on the timing of moisturizing. The goal of this clinical study is to evaluate the preference of moisturizing while showering/bathing compared to after towel drying in adolescents aged 12-18 with eczema. The main question it aims to answer are:

* Which moisturization technique is preferred: while showering/bathing or after towel drying?
* How do these techniques affect investigator-assessed eczema severity, patient-reported itch scores, and objective skin hydration measurements?

Researchers will compare applying moisturizer while in the shower/bath to after towel drying and to which technique is preferred among participants and if there are different effects on eczema and skin hydration.

Participants will:

* Apply moisturizer while showering/bathing for one month and after towel drying for one month.
* Complete questionnaires on moisturization technique, skin feel, and itchiness.
* Undergo skin hydration measurements using a Corneometer® CM825 device.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Atopic Dermatitis (AD) Atopic Dermatitis (Eczema)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Moisturizing while in shower/bath

Group Type EXPERIMENTAL

Moisturizing while in shower/bath

Intervention Type BEHAVIORAL

Applying moisturizer in the shower/bath.

Moisturizing after towel drying

Group Type EXPERIMENTAL

Moisturizing after towel drying

Intervention Type BEHAVIORAL

Applying moisturizer out of the shower/bath after towel drying.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Moisturizing while in shower/bath

Applying moisturizer in the shower/bath.

Intervention Type BEHAVIORAL

Moisturizing after towel drying

Applying moisturizer out of the shower/bath after towel drying.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participants must have a diagnosis of atopic dermatitis/eczema.
* Participants must be between the age of 12-18.
* Participants must be able to bathe independently.
* Participants will be English speaking and able to complete questionnaires.

Exclusion Criteria

* Participants who use topical corticosteroids between one inch above the wrist and 1 inch below the elbow from 1 month on both arms prior to the study until the final visit.
* Participants who have a known allergy to the moisturizer cream (Cerave Moisturizing Cream) provided.
Minimum Eligible Age

12 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

L'Oreal

INDUSTRY

Sponsor Role collaborator

University of British Columbia

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Wingfield Rehmus

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

BC Children's Hospital

Vancouver, British Columbia, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Wingfield Rehmus, MD, MPH

Role: CONTACT

1-604-875-2606

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

H25-02646

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Xerosis and Use of Topical Moisturizer
NCT04341623 ACTIVE_NOT_RECRUITING NA
Effects of Treatments on Atopic Dermatitis
NCT01631617 RECRUITING PHASE2